RE:RE:RE:RE:Example of details involved in acquisition talks: like ONCY Anyone catch the parabolic upward movement (+4000% at one pt) Tempest Therapeutics had based on positive liver cancer data? Anyone think Oncy can mirror this market reaction during ESMO?